Koers Yubo International Biotech Limited
Aandelen
YBGJ
US9883661004
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,95 USD | -0,78% | 0,00% | +216,67% |
Omzet 2022 | 0,1 0,1 | Omzet 2023 | 0,6 0,57 | Marktkapitalisatie | 35,95 mln. 33,6 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -935K | Nettowinst (verlies) 2023 | -1 mln. -935K | EV/omzet 2022 | 116.560.264 x |
Nettoschuld 2022 | 772K 722K | Nettoschuld 2023 | 386K 360K | EV/omzet 2023 | 60.084.725 x |
K/w-verhouding 2022 |
-9,36
x | K/w-verhouding 2023 |
-30,1
x | Werknemers | 18 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 6,63% |
1 dag | -0,78% | ||
Lopende maand | -4,04% | ||
3 maanden | +216,67% | ||
6 maanden | +214,57% | ||
Lopend jaar | +216,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 01-01-19 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 01-01-19 |
Wang Yang
BRD | Director/Board Member | 45 | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 01-01-19 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 01-01-19 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 01-01-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+216,67% | 114 mln. | |
+1,98% | 43,84 mld. | |
+6,59% | 41,68 mld. | |
+45,09% | 41,25 mld. | |
-10,92% | 27,04 mld. | |
+7,73% | 25,53 mld. | |
-25,27% | 18,18 mld. | |
-2,28% | 12,29 mld. | |
+26,94% | 12,29 mld. | |
+6,57% | 11,15 mld. |